Arterial hypertension is the most prevalent cardiovascular risk factor in developed countries. 1 The absolute level of blood pressure (BP) is the guiding parameter for diagnosis and management, since it is strongly and positively associated with a higher incidence of adverse cardiovascular outcomes. 2,3 BP undergoes marked short-, mid-, and long-term oscillations (hours, days, weeks, months) in response to physical activity, sleep, genetic factors, or emotions, among others. Several studies have suggested that BP variability (BPV) is independently related to the incidence of cardiovascular events, 4-6 as well as to the development and severity of cardiac, vascular and renal target organ damage, and hypertension-related morbidity and mortality. [7] [8] [9] [10] [11] [12] A major problem when interpreting these findings is the lack of a homogenous and reproducible quantitative test for measuring BPV. Indeed, there is no gold-standard method defining how the BPV should be measured, with what equipment, for how long or what index to use. Methods used for estimating BPV include intraarterial catheters, 13 clinical measurements in consultation, 4,14 home self-measurement (SMBP) 6,15 and ambulatory BP monitoring (ABPM). 16, 17 Each method reflects the BPV over different periods of time: beat-to-beat BPV-catheter-based measurements-reflecting very-short-term changes, ABPM representing shortterm and SMBP and clinic BPV providing information on mid-to-long-term changes. Moreover, scientific advances have revealed another layer of complexity including further factors and interactions that modulate each type of BPV differently. 18 In addition, the BPV can be measured using various indices. Although the SD is the most used, some authors have suggested that the "average real variability (ARV)" 19 as well as other indices that calculate the BPV independently of the absolute mean such as the "coefficient of variation (CV)", 18
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the "variability independent of the mean" 4 or the "residual BP variability", 18 have greater value.
The purpose of this study was to evaluate the correlation existing among short-, mid-, and long-term determinants of BPV obtained by clinic BP, SMBP, and ABPM measurements in a sample of hypertensive patients, to ascertain whether these determinants define a consistent and homogeneous behavior or, on the contrary, identify different aspects of this not-yet well understood phenomenon.
MATERIAL AND METHODS

Study design and population
The present study, an observational, descriptive, and transversal design, was conducted with a sample of essential hypertensive patients. Recruitment involved consecutive sampling in 2 health centers of urban characteristics. Inclusion criteria were as follows: essential hypertension diagnosed for at least 5 years without treatment changes within the 3 months prior to the beginning of the study. Patients with a nonregular sleep habit or with any psychological or social factor which might interfere with the study protocol (such as nonattendance to the scheduled visits or fail to fully collaborate with the planned self-measurements) were excluded from the study. Hypertension was managed according to the European Society of Hypertension recommendations. 2 The study was carried out according to the Helsinki Declaration and was approved by the Ethics Research Committee of our health area. Signed written informed consent forms were obtained from all participants at the time of inclusion (recruitment from September 2015 to April 2016).
The sociodemographic variables collected were age, gender, weight, height, waist circumference, together with clinical variables such as years since diagnosis of hypertension, presence of active smoking (defined as consuming ≥ 1 cigarette/day in the last month), active alcoholism (consumption of > 280 g of alcohol/week in men or > 140 g/week in women), established cardiovascular disease, and pharmacological treatment. All participants underwent a basic blood analysis at their health center and were then referred to the hospital for follow-up (Figure 1 ).
BP measurement methods
Clinical BP. Patients had successive weekly baseline BP measurements taken by their primary care physician for 8 consecutive weeks (morning, always at the same time). The BP was measured according to the international clinical recommendations, 2 seated with their dominant arm supported at the level of the heart and after 5 minutes of rest. Appropriate cuffs suitable for different arm sizes were used. At each visit, 3 consecutive measurements were performed, separated by an interval of 1-2 minutes. Clinical BP was considered valid when at least 6 out of 8 visits with BP determinations were obtained. The total number of BP readings were 24. An internationally validated (Dabl Educational Trust and British Hypertension Society protocols) device (M6 Comfort HEM-7221-E8, Omron Healthcare, Kyoto, Japan) 20 was used in all patients. The mean BP of the visit was calculated as the arithmetic mean of all measurements.
SMBP. Two SMBP sets were performed for 2 nonconsecutive weeks. Patients were instructed to measure their BP with an M6 Comfort sphygmomanometer HEM-7221-E8 Figure 1 . Study timeline. Zero to 60 represents the timeframe (days) for BP follow-up. Abbreviations: 3t/week, measurements taken during 3 days per week; ABPM, ambulatory blood pressure monitoring; BP, blood pressure; SMBP, self-measurement of blood pressure.
(Omron Healthcare). 20 As recommended by international BP measurement guidelines, 21 BP was recorded in the morning and in the evening (referred as night), but also at noon, in an attempt to assess BP behavior and BPV more accurately. After 5 minutes of rest in a seated position, 3 measurements were taken each time, separated by 2 minutes. Each patient kept records of 3 consecutive days for each SMBP, with 54 BP readings in total for both sets of SMBP (3 readings each time, 3 shifts per day, 3 days per SMBP set, 2 SMBP sets in total). The mean BP for the SMBP test was calculated as the arithmetic mean of all the measurements.
ABPM. All participants underwent a single 24-hour ABPM anytime between day 0 and 56 ( Figure 1) . A properly calibrated M24/7 BP-5 recorder (Omron Healthcare), validated by the British Hypertension Society, was used. 22 Measurements were set every 20 minutes during daytime (defined according to patients' sleeping habits: time between awakening and bedtime) and every 40 minutes during nighttime. Readings with <75% valid measurements were rejected and a second ABPM was performed. Twenty-four hours, daytime, and nighttime means were calculated as the arithmetic mean of the measurements taken during each period.
Indices and determinants of variability
The determinants of BPV were calculated for both systolic and diastolic BP using "the indices SD, ARV, and CV" of all 3 measurement methods. The CV was obtained by dividing the SD by the average BP level. 18 The ARV was calculated as the average of the differences between consecutive BP measurements. 19 For each measurement method, the "main" BPV was calculated, reflecting the BPV of the period in which the method makes estimations: long-term (weeks) for clinic BP, midterm (days) for SMBP, and short-term (hours) for ABPM. Other "determinants" of "partial" BP and BPV were also calculated. These reflect the BP and BPV over shorter periods of time within the main predefined overall period (for instance, from SMBP measurements we also calculated indicators of shorter-term BPV such as morning, noon, and night subperiods, among others). Table 1 and Supplementary Information 1 summarize and explain how the BPV determinants were calculated.
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Statistical analyses and sample size calculation
To evaluate the relationship between 2 "determinants" of BPV, a point cloud and a linear regression analysis was generated. The SE of the estimation was calculated using the minimum squared method and the Pearson correlation coefficient (coefficient of determination, expressed as R). 23 Quadratic and cubic regressions were also explored graphically and numerically (polynomial regression) when graphic information suggested a potential relationship. 24 The statistical inference focused on testing the hypothesis that establishes the zero value for the regression and the correlation coefficients.
In order to calculate the appropriate sample size, we consider as null hypothesis that in population there is no correlation and as alternative hypothesis that the population correlation is R = 0.50 (or R 2 = 0.25), establishing as critical rejection region any P value less than 0.05. The power is 99.98% with n = 100. In case that we refer to a much more modest alternative, with population correlation R = 0.30, the power is 87%.
RESULTS
A total of 108 patients were included in the study. Two patients were excluded due to inadequate SBPM data collection, another patient due to incomplete filling of the clinic BP data log and one more because he did not attend the scheduled appointment. This resulted in 104 patients comprising the final sample and subsequently completing the study. All patients were receiving at least 1 hypertensive drug. Baseline characteristics of the sample are shown in Table 2 . Main blood pressure variability (main)
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The mean BP as well as the BPV determinants "calculated by SD, ARV, and CV" were determined for each method ( Table 3) . As shown, the determinants of BPV derived from ABPM showed higher mean values than those obtained for clinic or SMBP.
The correlation of absolute systolic and diastolic BP means between the different methods was high. Clinic-SMBP systolic BP (Pearson coefficient R 2 = 0.43; P < 0.001) and SMBP-ABPM diastolic BP (R 2 =0.45; P < 0.001) showed the highest degrees of correlation ( Figure 2, panel a) , while the clinic-ABPM diastolic BP relationship (R 2 = 0.28; P < 0.001) was the weakest. Likewise, "partial" BP means (not variability) were correlated among methods, obtaining significant correlations in all cases, with a maximum of R 2 of 0.45 (P < 0.001) for the clinic-SMBP systolic BP relationship.
No significant correlations among the main BPV determinants were found for most of the comparisons (P > 0.05). The strongest correlation (R 2 = 0.17, P < 0.001) was found when comparing the systolic main clinic BPV and main SMBP BPV, estimated with ARV ( Figure 2, panel b) .
The correlation between the determinants of BPV calculated within the same method was also very weak or absent in most cases. The best correlation was obtained when comparing diastolic morning inteshifts SMBP BPV with morning intermeans SMBP BPV (R 2 = 0.21, P < 0.001), estimated with CV ( Figure 2, panel c) .
Finally, we studied the correlation of partial BPV determinants between methods, which theoretically reflect the BPV that exists in similar periods of time. All the determinants reflecting short-term BPV were correlated, as was the case with the determinants that reflect mid-and long-term BPV ( Table 1 ). The correlation coefficient was low or nonexistent for all associations. The best correlation was found when comparing the systolic main clinic BPV with morning intershifts SMBP BPV, with a modest R 2 = 0.22 (P < 0.001) ( Figure 2, panel d) . The remaining correlations obtained R 2 <0.15. No quadratic or cubic regression provided any more useful information or led to any significant relationship. The results and level of significance of all the BPV correlations calculated using SD, ARV, and CV are shown in Table 4 .
DISCUSSION
These results show that the correlation between the different BPV parameters obtained with different methods was indeed very weak, suggesting that different aspects of the overall variability phenomenon are being measured. Neither good correlations were found when comparing BPV determinants that theoretically reflect physiologically similar time periods.
To date, the scientific literature on BPV has been difficult to interpret due to the fact that no gold-standard or specific guidelines have been agreed upon. To our knowledge, the present study is the first that correlates not only the BPV of different measurement methods with each other, but also assesses "between-methods" determinants of temporally similar (partial) BPV to determine in-depth whether the BPV values identified by the different methods are an expression of a single phenomenon.
An important aspect of the present study is that, "betweenmethods", absolute means of BP were highly correlated. Other studies such as that of Souza 25 reported BP correlation levels comparable to ours (R 2 clinic/ABPM = 0.57, R 2 clinic/ SMBP = 0.17, and R 2 SMBP/ABPM = 0.57). In our view, the BP means correlation reflect a correct methodology for data collection thus supporting the validity of our conclusions.
Among the 3 measurement methods, ABPM reported the highest BPV values (Table 3) , independently of the "index" used (SD, CV, or ARV). Juhanoja et al. 26 evaluated the BPV using SMBP, ABPM, and clinic BP in 461 patients distributed into 2 cohorts, including a general and an untreated hypertensive population samples. As in our case, the BPV obtained with ABPM showed higher levels than the corresponding values obtained with SMBP and clinic BP (SD systolic/diastolic ABPM = 13.6/10). 26 This may be due to the fact that ABPM is the only method of measurement that takes into account BP both at rest and during normal daily activities, so the "around-the-mean" range of pressures obtained is higher than when clinic or SMBP are used. Table 4 . Abbreviations: ABPM, ambulatory blood pressure monitoring; ARV, average real variability; CV, coefficient of variation; SMBP, self-measurement of blood pressure. All correlations are expressed as R 2 (P value). Abbreviations: ABPM, ambulatory blood pressure monitoring; ARV, average real variability; BPV, blood pressure variability; CV, coefficient of variation; DBP, diastolic blood pressure; SBP, systolic blood pressure; SMBP, self-measurement of blood pressure.
In our sample, the "between-methods" main BPV correlations were poor. None of the parameters of main BPV showed consistent correlations to each other. Juhanoja et al. assessed the correlation among the BPV in clinic, SMBP, and ABPM in 226 normotensive and 235 hypertensive patients. 26 As in the present study, they found that the strength of the "between-methods" (clinic, SMBP, and ABPM) correlations was at best weak, with many nonsignificant correlations and a maximum R 2 = 0.07, similar to our data (R 2 = 0.17).
No other study had attempted to correlate BPV among the 3 measurement methods we describe. Wei et al. determined the correlation among beat-to-beat BPV, SMBP, and ABPM, calculated by ARV in 256 hypertensive patients. Once more, the correlation coefficients obtained were comparable to ours, with many nonsignificant correlations (all correlations below R 2 < 0.26, P < 0.05). 27 Muntner et al. compared BPV by ABPM and clinic BP, using SD and ARV in 174 adults. 28 Between-groups correlations were extremely low, with a maximum R 2 = 0.25 (systolic clinic BPV − daytime ABPM BPV), and not significant in many cases, again similar to the present results.
The most plausible physiopathological explanation for these findings is that the main BPV of each measurement method reflects the BPV of a different time period. Mancia et al. reported that seasonal changes, adherence to treatment, possible measurement errors, and arterial stiffness (among others) do not influence short-, mid-, and longterm BPV in a similar fashion, with factors such as sleep/ awake rhythm or sympathetic tone mainly modulating episodic BPV in the short term. 29 Such factors were not taken into account in our study and thus, should be recognized as actual limitations of our results. In fact, performing more than 1 ABPM could have contributed to diluting the effect that these factors might have on the BPV inherent in a single ABPM measurement. In our paper, there was no correlation between the determinants of BPV within the same method, which reinforces the idea that the determinants of variability in the short, mid, or long term do not represent the same phenomenon and, as a result, are not interchangeable.
In order to test this hypothesis in more depth, partial BPV determinants were calculated. This is an original aspect of the present study. Partial BPV theoretically reflects the tensional variability of shorter periods of time within the main predefined overall period of each measurement method (Table 1 and Supplementary Information 1) . It was thought there might be a higher level of correlation when physiologically similar periods of observation were compared using different methods but, once more, the results were poor, with low correlation values at best (correlation between systolic intradays clinic BPV − morning intershifts SMBP BPV resulted in R 2 = 0.22, P < 0.001). To our knowledge, no studies have been published correlating physiologically similar variabilities using all 3 methods.
The potential reasons why the partial and temporally similar variabilities did not correlate are diverse. First, it seems likely that some factors affect some measurement methods more than others. For instance, the sympathetic tone itself (not measured in our patients) has been shown to be more pronounced as a result of clinic-based measurements-when an alarm reaction is more likely to occur-compared to measurements taken with ABPM or SMBP. Moreover, data regarding the participants' activities when performing SBPM and ABPM were not collected and this fact was certainly a limiting factor since nonstandardized measures (mainly at-noon SBPM readings) could have been influenced by patient's habits that might operate as confounding factors that were not controlled in our study. Notwithstanding the value of SBPM taken at this time of the day is limited, we still believed that this information did not prejudice to that obtained by the guidelines recommended measurements 1, 2, 21 and that it was worthwhile being reported and discussed here, although it should be addressed in a separate study specifically designed to tackle these limitations. Another important factor that may play a relevant role in BPV is antihypertensive treatment, which is more prone to influence BP obtained by clinic and SBPM means, even if we are considering short-term BPV determinants. 29 The rationale for this is that when calculating clinic-and SBPM-partial BPV determinants (see method in Supplementary Information 1) the average of all partial values was calculated to provide an overall figure (otherwise a random partial BPV period would be needed for our calculations). Moreover, we did not assess the relationship between the different antihypertensive treatment regimens with BPV, which is a limiting factor.
Thirdly, it is possible the different methods used to estimate BPV might lack sufficient reproducibility for any great importance to be given to the way in which and the time at which the measurements are obtained. In this sense, although some authors accept the influence of the abovementioned factors that govern BPV, 2,13,18,29 others tend to consider BPV as a random or erratic phenomenon, this last being the reason why so few studies have found that BPV adds prognostic value over and above the information contained in the mean BP. 30, 31 In this regard, Muntner et al. published a study involving more than 15,000 patients in which they concluded that intravisit variability-shortterm BPV, similar to our intraday clinic BPV-was not reproducible nor associated with increased cardiovascular risk. 32 In addition to the above-mentioned limitations, another factor to emphasize of the present study is that other indices of BPV were not measured, such as the "variability independent of the mean or the residual BPV". The methodology used prevented its valid calculation. Further studies that assess in depth the correlation of BPV estimated by these other indices are needed.
In conclusion, the present data support that BPV should not be considered a global phenomenon. Short-, mid-, and long-term BPV determinants are not interchangeable and the measurement methods and indices used to estimate BPV should also be considered to avoid confusion or pitfalls. General consensus regarding the indications for the use of BPV measurement is still needed.
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